BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 30073253)

  • 1. Dornase Alfa Ototoxic Effects in Animals and Efficacy in the Treatment of Clogged Tympanostomy Tubes in Children: A Preclinical Study and a Randomized Clinical Trial.
    Chan KH; Allen GC; Kelley PE; Streubel SO; Friedman NR; Yoon P; Gao D; Ruiz AG; Jung TTK
    JAMA Otolaryngol Head Neck Surg; 2018 Sep; 144(9):776-780. PubMed ID: 30073253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety, tolerability, and effect of a single aural dose of Dornase alfa at the time of ventilation tube surgery for otitis media: A Phase 1b double randomized control trial.
    Thornton RB; Jeffares S; Seppanen E; Jacoby P; Kirkham LS; Bennett H; Coates HL; Vijayasekaran S; Brennan-Jones CG; Richmond PC
    Int J Pediatr Otorhinolaryngol; 2024 Feb; 177():111832. PubMed ID: 38215661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 12-week administration of dornase alfa in patients with advanced cystic fibrosis lung disease. Pulmozyme Study Group.
    McCoy K; Hamilton S; Johnson C
    Chest; 1996 Oct; 110(4):889-95. PubMed ID: 8874241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety and Efficacy of Intratympanic Ciprofloxacin Otic Suspension in Children With Middle Ear Effusion Undergoing Tympanostomy Tube Placement: Two Randomized Clinical Trials.
    Mair EA; Park AH; Don D; Koempel J; Bear M; LeBel C
    JAMA Otolaryngol Head Neck Surg; 2016 May; 142(5):444-51. PubMed ID: 26985629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Intrapleural Tissue Plasminogen Activator and Dornase Alfa vs Tissue Plasminogen Activator Alone in Children with Pleural Empyema: A Randomized Clinical Trial.
    Livingston MH; Mahant S; Connolly B; MacLusky I; Laberge S; Giglia L; Yang C; Roberts A; Shawyer A; Brindle M; Parsons S; Stoian C; Walton JM; Thorpe KE; Chen Y; Zuo F; Mamdani M; Chan C; Loong D; Isaranuwatchai W; Ratjen F; Cohen E
    JAMA Pediatr; 2020 Apr; 174(4):332-340. PubMed ID: 32011642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dornase alfa as postoperative therapy in cystic fibrosis sinonasal disease.
    Cimmino M; Nardone M; Cavaliere M; Plantulli A; Sepe A; Esposito V; Mazzarella G; Raia V
    Arch Otolaryngol Head Neck Surg; 2005 Dec; 131(12):1097-101. PubMed ID: 16365224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dornase alfa for cystic fibrosis.
    Jones AP; Wallis C
    Cochrane Database Syst Rev; 2010 Mar; (3):CD001127. PubMed ID: 20238314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pilot study of dornase alfa (Pulmozyme) therapy for acquired ventilator-associated infection in preterm infants.
    Scala M; Hoy D; Bautista M; Palafoutas JJ; Abubakar K
    Pediatr Pulmonol; 2017 Jun; 52(6):787-791. PubMed ID: 28052587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A two-year randomized, placebo-controlled trial of dornase alfa in young patients with cystic fibrosis with mild lung function abnormalities.
    Quan JM; Tiddens HA; Sy JP; McKenzie SG; Montgomery MD; Robinson PJ; Wohl ME; Konstan MW;
    J Pediatr; 2001 Dec; 139(6):813-20. PubMed ID: 11743506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrapleural Dornase and Tissue Plasminogen Activator in pediatric empyema (DTPA): a study protocol for a randomized controlled trial.
    Livingston MH; Mahant S; Ratjen F; Connolly BL; Thorpe K; Mamdani M; Maclusky I; Laberge S; Giglia L; Walton JM; Yang CL; Roberts A; Shawyer AC; Brindle M; Parsons SJ; Stoian CA; Cohen E
    Trials; 2017 Jun; 18(1):293. PubMed ID: 28646887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Randomized Trial of Dornase Alfa for Acute Respiratory Distress Syndrome Secondary to Covid-19.
    Holliday ZM; Earhart AP; Alnijoumi MM; Krvavac A; Allen LH; Schrum AG
    Front Immunol; 2021; 12():714833. PubMed ID: 34745093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Possibilities of using recombinant human deoxyribonuclease I in otorhinolaryngology].
    Eremeeva KV; Svistushkin VM; Sinkov EV; Mironova AR; Sobolev VP
    Vestn Otorinolaringol; 2023; 88(2):59-66. PubMed ID: 37184556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ototoxicity of topical ciprofloxacin/dexamethasone otic suspension in a chinchilla animal model.
    Daniel SJ; Munguia R
    Otolaryngol Head Neck Surg; 2008 Dec; 139(6):840-5. PubMed ID: 19041513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Respiratory evolution of patient with mucoviscidosis treated with mucolytic agents plus dornase alfa].
    Derelle J; Bertolo-Houriez E; Marchal F; Weber M; Virion JM; Vidailhet M
    Arch Pediatr; 1998 Apr; 5(4):371-7. PubMed ID: 9759155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human deoxyribonuclease shortens ventilation time in young, mechanically ventilated children.
    Riethmueller J; Borth-Bruhns T; Kumpf M; Vonthein R; Wiskirchen J; Stern M; Hofbeck M; Baden W
    Pediatr Pulmonol; 2006 Jan; 41(1):61-6. PubMed ID: 16265663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is a longer time interval between recombinant human deoxyribonuclease (dornase alfa) and chest physiotherapy better? A multi-center, randomized crossover trial.
    Wilson CJ; Robbins LJ; Murphy JM; Chang AB
    Pediatr Pulmonol; 2007 Dec; 42(12):1110-6. PubMed ID: 17955550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerosolized dornase alfa (rhDNase) for therapy of cystic fibrosis.
    Hodson ME
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S70-4. PubMed ID: 7881698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxymetazoline ototoxicity in a chinchilla animal model.
    Daniel SJ; Akinpelu OV; Sahmkow S; Funnell WR; Akache F
    Otolaryngol Head Neck Surg; 2012 Jan; 146(1):114-8. PubMed ID: 21846927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis.
    Fitzgerald DA; Hilton J; Jepson B; Smith L
    Pediatrics; 2005 Oct; 116(4):e549-54. PubMed ID: 16147970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and Safety of Ciprofloxacin Plus Fluocinolone in Otitis Media With Tympanostomy Tubes in Pediatric Patients: A Randomized Clinical Trial.
    Spektor Z; Pumarola F; Ismail K; Lanier B; Hussain I; Ansley J; Butehorn HF; Esterhuizen K; Byers J; Douglis F; Lansford B; Hernández FJ
    JAMA Otolaryngol Head Neck Surg; 2017 Apr; 143(4):341-349. PubMed ID: 28006041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.